| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/07/2003 | US6504007 GDNF receptor |
| 01/07/2003 | US6503888 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/07/2003 | US6503887 Peroral gene therapy of diabetes and obesity |
| 01/07/2003 | US6503886 Gene delivery; polypeptide conjugated to fibroblast growth factor fused to nucleic acid |
| 01/07/2003 | US6503881 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 01/07/2003 | US6503756 Antisense modulation of syntaxin 4 interacting protein expression |
| 01/07/2003 | US6503755 Particle transfection: rapid and efficient transfer of polynucleotide molecules into cells |
| 01/07/2003 | US6503754 Antisense modulation of BH3 interacting domain death agonist expression |
| 01/07/2003 | US6503752 Lymphotropic agents and vectors |
| 01/07/2003 | US6503749 Yeast strains possessing the interrupted ATF2 gene and their applications |
| 01/07/2003 | US6503748 Endogenous ketogulonigenium plasmid |
| 01/07/2003 | US6503747 Serotype-specific probes for Listeria monocytogenes |
| 01/07/2003 | US6503744 Prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an alpha 2,3- and an alpha 2,8-activity. A beta 1,4-GalNAc transferase and a beta 1,3-galactosyltransferase, gene expression vectors and cells |
| 01/07/2003 | US6503742 Ubiquitin ligases and uses related thereto |
| 01/07/2003 | US6503741 Polyketide synthase genes from Streptomyces venezuelae |
| 01/07/2003 | US6503738 Method of plasmid DNA production and purification |
| 01/07/2003 | US6503737 Isolated nucleic acids relating to the fkbA gene within the FK-520 polyketide synthase gene cluster |
| 01/07/2003 | US6503736 Antibodies to crosslinkers and methods for using the same |
| 01/07/2003 | US6503735 Polynucleotides encoding chemokine β-15 |
| 01/07/2003 | US6503733 Polynucleotides which identify and encode NANCH. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NANCH and a method for producing NANCH. Agonists, antibodies |
| 01/07/2003 | US6503732 An infectious modified Tobacco Mosaic Virus (TMV) virion comprising a coat protein (CP) or a movement protein (MP) gene is replaced with a nuclear inclusion protease (NIa) expression cassette for the expression of a heterologous |
| 01/07/2003 | US6503728 A nucleic acid comprising a nucleic acid sequence encoding pantropic hNT3 or hNGF having an alanine residue substituted at a position corresponding to D15 in hNT3 or D16 in hNGF, wherein the alanine substitution imparts trkB-binding such |
| 01/07/2003 | US6503722 Diagnostic tests and kits for Clostridium difficile |
| 01/07/2003 | US6503721 High-throughput assay for detection of ligand that binds preferential target sequences; obtain ligands, incubate with nucleotide sequences, monitor conformational adjustments, recover ligand that cause conformational adjustments |
| 01/07/2003 | US6503720 Method for quantification of an analyte |
| 01/07/2003 | US6503717 Detecting gene asociated with preferential phenotype; obtain preferential nucleotide sequences, transduce cells, culture cells, recover cell of preferential phenotype, monitor gene expression in recovered cells |
| 01/07/2003 | US6503716 Compositions and methods for extracting a nucleic acid |
| 01/07/2003 | US6503715 Solid support to which one or more specific Nucleic acid ligands is attached in a spatially defined manner. Each Nucleic acid ligand binds specifically and avidly to a particular Target molecule contained within a Test mixture, |
| 01/07/2003 | US6503714 Method of detecting a substance to be analyzed |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/07/2003 | US6503712 Methods and compositions for preparing a genomic library for knockout targeting vectors |
| 01/07/2003 | US6503709 Detection the presence of an antibiotic resistant mecA gene in a biological sample, comprising the general steps of (a) treating cells contained within a biological sample to expose target single- stranded nucleic acid molecules; (b) reacting |
| 01/07/2003 | US6503706 The invention addresses DNA-protein-complexes, proteins, DNA sequences and antibodies that are suitable for the detection of cells with an unlimited proliferation and tumor-formation potential. The invention further addresses methods for |
| 01/07/2003 | US6503704 Method, reagent and kit for genotyping human papilloma virus |
| 01/07/2003 | US6503703 Identification of host cell proteins that interact with viral proteins required for virus replication, and high throughput assays to identify compounds that interfere with the specific interaction between the viral and host cell protein. |
| 01/07/2003 | US6503533 Antisense ogligonucleotides against Hepatitis B viral replication |
| 01/07/2003 | US6503514 Attenuated strains of mycobacteria |
| 01/07/2003 | US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 01/07/2003 | US6503511 Derivatives of choline binding proteins for vaccines |
| 01/07/2003 | US6503508 Detergents |
| 01/07/2003 | US6503504 In vitro cell growth to form tissue containing at least partially foreign DNA sequence which mediates production of the bioactive compound; implanting mass into an organism; treating diseases |
| 01/07/2003 | US6503501 Targetable vector particles |
| 01/07/2003 | US6503499 Viral particle comprising gene of interest operably linked to a promoter and envelope protein affixed with bifunctional adapter and a biotin molecule; internalizing into target cell for transduction and gene expression |
| 01/07/2003 | US6503498 Apolipoprotein A-1 adenovirus vector compositions and methods |
| 01/07/2003 | US6503452 Biosensor arrays and methods |
| 01/07/2003 | CA2415199A1 Genes and their genetic products pertinent to microsatellite instable (msi+) tumours |
| 01/07/2003 | CA2239753C Novel semaphorin z and gene encoding the same |
| 01/07/2003 | CA2220923C Process of high purity albumin production |
| 01/07/2003 | CA2190373C Yeast strains |
| 01/07/2003 | CA2182398C Nucleic acid transfection efficiency increase by use of isopropanol in aqueous solutions |
| 01/07/2003 | CA2113363C Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 01/07/2003 | CA2104598C Methods for selection of recombinant host cells expressing high levels of a desired protein |
| 01/07/2003 | CA2100167C Description process of the antibody (ab) repertoires and of the t-cell receptors (tcr) of an individual's immune system |
| 01/07/2003 | CA2089666C Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/07/2003 | CA2059657C Process for the detection of a nucleotidic sequence by use of the sandwich hybridation technique |
| 01/07/2003 | CA1341415C Targeted multifunctional proteins |
| 01/06/2003 | CA2392549A1 Acetyl-coa carboxylase subunits |
| 01/04/2003 | CA2351156A1 A bioprocess for the generation of pluripotent cell derived cells and tissues |
| 01/03/2003 | WO2003001249A2 Modulating photoreactivity in a cell |
| 01/03/2003 | WO2003001212A2 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | WO2003001178A2 Configurable dynamic three dimensional array |
| 01/03/2003 | WO2003000941A2 Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same |
| 01/03/2003 | WO2003000933A1 Dual resonance energy transfer nucleic acid probes |
| 01/03/2003 | WO2003000930A2 Nucleotide sequences involved in plant disease resistance |
| 01/03/2003 | WO2003000928A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 01/03/2003 | WO2003000927A2 Method for the determination of telomere length |
| 01/03/2003 | WO2003000923A2 Maternal effect gametophyte regulatory polynucleotide |
| 01/03/2003 | WO2003000922A2 Chimeric immunomodulatory compounds and methods of using the same |
| 01/03/2003 | WO2003000919A2 Method for detecting diseases caused by chromosomal imbalances |
| 01/03/2003 | WO2003000916A2 Telomerase expression repressor proteins and methods of using the same |
| 01/03/2003 | WO2003000909A2 Methods for the manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes |
| 01/03/2003 | WO2003000908A1 A method for introducing a nucleic acid into a eukaryotic cell |
| 01/03/2003 | WO2003000907A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 01/03/2003 | WO2003000906A2 Plant disease resistance genes |
| 01/03/2003 | WO2003000905A2 Identification and characterization of plant genes |
| 01/03/2003 | WO2003000904A2 Identification and characterization of plant genes |
| 01/03/2003 | WO2003000903A2 Regulation of human nek-like serine/threonine protein kinase |
| 01/03/2003 | WO2003000902A1 Aphidicolin biosynthase cluster |
| 01/03/2003 | WO2003000900A1 White spot syndrome virus vaccine |
| 01/03/2003 | WO2003000899A1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 01/03/2003 | WO2003000898A1 Plant genes involved in defense against pathogens |
| 01/03/2003 | WO2003000897A2 Identification and characterization of phosphate transporter genes |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000895A1 Yeast transformation vector system comprising multicopy paromomycin-resistance gene |
| 01/03/2003 | WO2003000894A1 Polynucleotide vaccine |
| 01/03/2003 | WO2003000893A2 Nucleic acids encoding g protein-coupled receptors |
| 01/03/2003 | WO2003000891A2 Protein-protein interactions in the inner ear |
| 01/03/2003 | WO2003000889A2 Identification of ses-1 and the uses of the same |
| 01/03/2003 | WO2003000888A2 Method for separating bacterial cells and cell components |
| 01/03/2003 | WO2003000887A1 Polynucleotide probe and primer originating in hepatitis e virus of japanese, chips having the same, kits having the same and method of detecting hepatitis e virus using the same |
| 01/03/2003 | WO2003000886A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/03/2003 | WO2003000885A1 Process for constructing mutant |
| 01/03/2003 | WO2003000882A2 Transgenic models for glucose homeostasis comrpising human gsk-3 |
| 01/03/2003 | WO2003000881A2 Method of plasmid stabilisation by in vivo deleting the antibiotic resistence and selecting with an essential gene |
| 01/03/2003 | WO2003000880A2 Homoaconitase as a target for fungicides |
| 01/03/2003 | WO2003000879A2 Novel promoters inducible by dna damaging conditions or agents and uses thereof |
| 01/03/2003 | WO2003000878A2 Use of fkbp chaperones as expression tool |
| 01/03/2003 | WO2003000877A2 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | WO2003000874A2 Regulation of human serine/threonine protein kinase nek3 |
| 01/03/2003 | WO2003000872A1 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |